HaTay Pharmaceutical JSC

HaTay Pharmaceutical JSC Acquisitions (Net)

The Acquisitions (Net) of HaTay Pharmaceutical JSC (DHT.VN) as of Nov 3, 2026 is 17.36 B VND. In the previous year, Acquisitions (Net) was -43.09 B VND — a change of -140.30% (higher).

Acquisitions (Net)

17.36 BVND

YoY

-140.30%

Last updated:

Acquisitions (Net) of HaTay Pharmaceutical JSC is 2024 17.36 B VND. Acquisitions (Net) of HaTay Pharmaceutical JSC was 2023 -43.09 B VND. It decreases by -140.30% higher compared to the previous year.

The HaTay Pharmaceutical JSC Acquisitions (Net) history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Acquisitions (Net)
Date
Acquisitions (Net)
Jan 1, 2017
113.53 M VND
Jan 1, 2018
-16.17 B VND
Jan 1, 2019
22.04 B VND
Jan 1, 2020
2.42 B VND
Jan 1, 2021
-349.65 B VND
Jan 1, 2022
323.35 B VND
Jan 1, 2023
-43.09 B VND
Jan 1, 2024
17.36 B VND
The HaTay Pharmaceutical JSC Acquisitions (Net) history
YEARAcquisitions (Net)YoY
17.36 BVND-140.30%
-43.09 BVND-113.33%
323.35 BVND-192.48%
-349.65 BVND-14,519.04%
2.42 BVND-89.00%
22.04 BVND-236.32%
-16.17 BVND-14,341.77%
113.53 MVND-87.07%
878.29 MVND-38.94%
1.44 BVND-146.07%
-3.12 BVND—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

HaTay Pharmaceutical JSC Stock analysis

What does HaTay Pharmaceutical JSC do? Ha Tay Pharmaceutical JSC generates revenue through the manufacturing, import, and export of pharmaceuticals, cosmetics, and medical equipment. The company sells its products via wholesale and retail channels, targeting healthcare providers, pharmacies, and consumers. It also engages in the production and trading of cosmetic products, supplemental food, and laboratory chemicals, alongside medical equipment and supplies. The firm completed the acquisition of a 50.626% stake in Ha Tay Pharmaceutical and Medical Equipments Joint Stock Company in 2013, expanding its market presence in pharmaceuticals and medical equipment. The company operates in the pharmaceutical sector, serving healthcare institutions, retail pharmacies, and end consumers. Its revenue streams include the sale of drugs, cosmetics, medical equipment, and related supplies. Additional income comes from supermarket operations, real estate leasing, and vocational training services, though these are secondary to its core pharmaceutical business. Ha Tay Pharmaceutical JSC's primary customers are healthcare providers, pharmacies, and consumers purchasing pharmaceuticals, cosmetics, and medical equipment. The firm's product portfolio spans drugs, vaccines, cosmetic products, supplemental food, and laboratory chemicals, with a focus on manufacturing and trading. The acquisition of the 50.626% stake in Ha Tay Pharmaceutical and Medical Equipments Joint Stock Company has strengthened its position in the medical equipment market. HaTay Pharmaceutical JSC is one of the most popular companies on Eulerpool.

Frequently Asked Questions about HaTay Pharmaceutical JSC stock

Acquisitions (Net) of HaTay Pharmaceutical JSC is 17.36 B VND in 2024.

Acquisitions (Net) of HaTay Pharmaceutical JSC changed from -43.09 B VND to 17.36 B VND, representing a -140.30% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Acquisitions (Net) HaTay Pharmaceutical JSC since 2006 – with annual values, charts, and detailed analysis.

Net acquisitions represent the cash spent on acquiring other businesses, net of divestitures. Large acquisitions can transform a company's growth trajectory.

Acquisitions (Net)'s VND is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Acquisitions (Net)'s HaTay Pharmaceutical JSC historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — HaTay Pharmaceutical JSC

All Key Metrics — HaTay Pharmaceutical JSC